Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 11 of 11

List	Outcome	Time frame	Description
Primary	Acceptability of MBSR for Individuals with HS as Assessed by the Acceptability of Intervention Measure (AIM)	8 weeks	This tool measures the acceptability of a given intervention. Questions range from 1 to 4. The total score range is 4 to 20. Higher scores indicate greater acceptability of the intervention.
Primary	Acceptability of MBSR for Individuals with HS as Assessed by the Theoretical Framework of Acceptability (TFA)	8 weeks	This tool measures the acceptability of a given intervention and has been adapted to fit the needs of our HS study. This tool has 7 Constructs + 1 General Acceptability Construct, however we did not include the Ethical construct due ambiguity regarding the applicability of the construct to the study (i.e., 6 Constructs + 1 General Acceptability Construct). Questions range from 1 and 5. The total mean score range for our adapted TFA is 6 to 30, and for the General acceptability item is 1 to 5. Higher scores indicate greater acceptability of the intervention.
Secondary	Intervention Adherence as Assessed by MBSR Course Attendance	8 weeks	Intervention adherence will be measured by the percentage of participants who attended at least six of the eight group sessions.
Secondary	Study Retention as Assessed by the Percent of Participants who Complete the Study	8 weeks	Study retention will be measured by the number of participants who completed survey assessments at the 8-week follow-up time-point divided by the number of participants who enrolled in the study, multiplied by 100.
Secondary	Feasibility of MBSR for Individuals with HS as Assessed by the Feasibility of Intervention Measure (FIM)	8 weeks	This tool measures the feasibility of a given intervention. Questions range from 1 to 4. The total score range is 4 to 20. Higher scores indicate greater feasibility of the intervention.
Other	Pain Visual Analog Scale	Change From Baseline to 8 Weeks, Change From Baseline to 12 Weeks, Change From Baseline to 20 Weeks	A simple, one-dimensional measurement tool used to rate the intensity of a patient's pain. Range is 0 to 10. Higher scores indicate greater pain. The reported outcome is the change in Visual Analog Scale score from baseline to 8 weeks.
Other	Brief-COPE (Coping Orientation to Problems Experienced)	Change From Baseline to 8 Weeks, Change From Baseline to 12 Weeks, Change From Baseline to 20 Weeks	This questionnaire is designed to measure the effective and ineffective methods the respondent uses to cope with stressors. Questions range from 1 to 4. The total score range is 28 to 112. There are three overarching sub-scales: * The Problem-Focused Coping range is 8 to 32. * The Emotion-Focused Coping range is 12 to 48. * The Avoidant Coping range is 8 to 32. Higher scores in each sub-scale indicate greater extent of using those methods to cope with stressors. The reported outcome is the change in Brief-COPE sub-scale score from baseline to 8 weeks.
Other	Perceived Stress Scale	Change From Baseline to 8 Weeks, Change From Baseline to 12 Weeks, Change From Baseline to 20 Weeks	This questionnaire measures the degree to which situations in one's life are appraised as stressful. Questions range from 0 to 4. The total score range is 0 to 40. Higher scores indicate higher perceived stress. The reported outcome is the change in Perceived Stress Scale scores from baseline to 8 weeks.
Other	Five Facet Mindfulness Questionnaire - Short Form	Change From Baseline to 8 Weeks, Change From Baseline to 12 Weeks, Change From Baseline to 20 Weeks	The 5 facets are Observing, Describing, Detaching, Acting mindfully, and Loving yourself. Each individual facet is given a score from summing up questions related to that facet. This gives insight into the patient's mindfulness in the past month. Questions range from 1 to 5. Higher scores indicate more frequent actions relating to the facet title. For example, a higher score in "Observing" translates to the respondent being more observant and paying attention to their surroundings. The reported outcome is the change in Five Facet Mindfulness Questionnaire scores from baseline to 8 weeks.
Other	Dermatology Life Quality Index	Change From Baseline to 8 Weeks, Change From Baseline to 12 Weeks, Change From Baseline to 20 Weeks	The DLQI is designed for use in patients over the age of 16 and provides insight into how the respondent's skin condition(s) has affected their life over the last week. Questions range from 0 to 3. The total score range is 0 to 30. Higher scores indicate a greater effect the skin condition(s) has on the respondent's life. The reported outcome is the change in Dermatology Life Quality Index scores from baseline to 8 weeks.
Other	Hidradenitis Suppurativa Quality of Life	Change From Baseline to 8 Weeks, Change From Baseline to 12 Weeks, Change From Baseline to 20 Weeks	This questionnaire is designed to measure how Hidradenitis Suppurativa has impacted the respondent over the past 7 days. Questions range from 0 to 4. The total score range is 0 to 68. There are three sub-scales: * The symptom score range is 0 to 16. * The activity-adaptation score range is 0 to 32. * The psychosocial score range is 0 to 20. Severity thresholds for the HiSQOL total score were identified for None, Mild, Moderate, Severe, and Very Severe, respectively: 0-4, 5-14, 15-21, 22-23, and ≥24 Severity thresholds for HiSQOL subscales for None, Mild, Moderate, Severe, and Very Severe, respectively: * Symptoms: 0-2, 3-4, 5-6, 7, and ≥8; * Activities-adaptations: 0-1, 2-4, 5-8, 9-12, and ≥13; * Psychosocial: 0, 1, 2, 3-5, and ≥6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07903948/registered

API reference For AI assistants